The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-2-(8-(methoxycarbonylamino)dibenzo[b,d]furan-3-sulfonamido)-3-methylbutanoic acid ID: ALA4764498
Cas Number: 1258003-93-8
PubChem CID: 46245329
Max Phase: Preclinical
Molecular Formula: C19H20N2O7S
Molecular Weight: 420.44
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COC(=O)Nc1ccc2oc3cc(S(=O)(=O)N[C@@H](C(=O)O)C(C)C)ccc3c2c1
Standard InChI: InChI=1S/C19H20N2O7S/c1-10(2)17(18(22)23)21-29(25,26)12-5-6-13-14-8-11(20-19(24)27-3)4-7-15(14)28-16(13)9-12/h4-10,17,21H,1-3H3,(H,20,24)(H,22,23)/t17-/m1/s1
Standard InChI Key: MKAIHDAGQJQAHA-QGZVFWFLSA-N
Molfile:
RDKit 2D
29 31 0 0 0 0 0 0 0 0999 V2000
33.7311 -7.1379 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.5312 -6.9255 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
33.9471 -6.3388 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.2563 -5.8712 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
36.4313 -5.8712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.1791 -5.0881 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3764 -4.9162 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8251 -5.5266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.0820 -6.3116 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8842 -6.4797 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8438 -4.6003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.5117 -5.0872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2652 -4.7522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.3521 -3.9304 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.6792 -3.4448 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.9284 -3.7826 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.7626 -2.6240 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.5152 -2.2859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5986 -1.4651 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
39.1844 -2.7685 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
39.9370 -2.4302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.7884 -7.7101 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.2380 -8.3247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4949 -9.1086 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4305 -8.1552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1735 -7.3712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8799 -8.7697 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9444 -9.7232 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.3023 -9.2782 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
5 4 1 0
4 12 1 0
11 6 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
15 17 1 0
17 18 1 0
18 19 2 0
18 20 1 0
20 21 1 0
9 2 1 0
2 22 1 0
22 23 1 0
23 24 1 0
23 25 1 1
25 26 1 0
25 27 1 0
24 28 2 0
24 29 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 420.44Molecular Weight (Monoisotopic): 420.0991AlogP: 3.15#Rotatable Bonds: 6Polar Surface Area: 134.94Molecular Species: ACIDHBA: 6HBD: 3#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.86CX Basic pKa: ┄CX LogP: 2.77CX LogD: -0.46Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.56Np Likeness Score: -1.01
References 1. Baggio C,Velazquez JV,Fragai M,Nordgren TM,Pellecchia M. (2020) Therapeutic Targeting of MMP-12 for the Treatment of Chronic Obstructive Pulmonary Disease., 63 (21): [PMID:33107733 ] [10.1021/acs.jmedchem.0c01285 ]